NCT02385110 Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis Status COMPLETED Phase PHASE2
NCT02378701 Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease Status COMPLETED Phase N/A
NCT02360930 Vincristine PK and PD in the AYA Population Compared to Younger Children Status UNKNOWN Phase N/A
NCT02360111 GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant Status TERMINATED Phase NA
NCT02356653 Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC Status RECRUITING Phase EARLY_PHASE1
NCT02356549 African American Cancer Clinical Trial Decisions: Testing Tailored Messages Status COMPLETED Phase NA
NCT02349698 A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT02347878 Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) Status UNKNOWN Phase PHASE4
NCT02345382 Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia Status COMPLETED Phase PHASE1
NCT02328885 Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02323867 Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02305979 Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies Status COMPLETED Phase N/A
NCT02305563 An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT02302846 Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission Status TERMINATED Phase PHASE2